| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1043065223 |
| P356 | DOI | 10.1038/SJ.ONC.1207869 |
| P698 | PubMed publication ID | 15361850 |
| P50 | author | Yukinari Kato | Q42292347 |
| Mika K Kaneko | Q90664257 | ||
| P2093 | author name string | Takashi Tsuruo | |
| Naoya Fujita | |||
| Motoki Osawa | |||
| Isoji Sasagawa | |||
| P2860 | cites work | Molecular identification of Aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors | Q28206434 |
| Evidence against a role of mouse, rat, and two cloned human t1alpha isoforms as a water channel or a regulator of aquaporin-type water channels | Q28275357 | ||
| T1 alpha protein is developmentally regulated and expressed by alveolar type I cells, choroid plexus, and ciliary epithelia of adult rats | Q28565537 | ||
| T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema | Q28577668 | ||
| T1alpha, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birth | Q28587220 | ||
| Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon | Q34380577 | ||
| Characterization and cloning of the E11 antigen, a marker expressed by rat osteoblasts and osteocytes | Q36822732 | ||
| Pathogenesis of adult testicular germ cell tumors. A cytogenetic model | Q37891858 | ||
| Differential expression of the c-kit proto-oncogene in germ cell tumours. | Q42513650 | ||
| Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. | Q53483907 | ||
| Testicular cancer in nine northern european countries | Q58411745 | ||
| Heterogeneity of intermediate filament expression in human testicular seminomas | Q58438777 | ||
| Expression of MAGE-antigens in normal tissues and cancer | Q73504314 | ||
| P433 | issue | 52 | |
| P921 | main subject | embryonal carcinoma | Q1451877 |
| diagnostic marker | Q129938486 | ||
| P304 | page(s) | 8552-8556 | |
| P577 | publication date | 2004-11-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors | |
| P478 | volume | 23 |
| Q52591453 | A Real-Time Near-Infrared Fluorescence Imaging Method for the Detection of Oral Cancers in Mice Using an Indocyanine Green-Labeled Podoplanin Antibody. |
| Q33985502 | A cancer-specific monoclonal antibody recognizes the aberrantly glycosylated podoplanin |
| Q37631100 | A critical role of platelet TGF-β release in podoplanin-mediated tumour invasion and metastasis |
| Q30487675 | A genetic expression profile associated with oral cancer identifies a group of patients at high risk of poor survival |
| Q57117084 | A safety study of newly generated anti-podoplanin-neutralizing antibody in cynomolgus monkey () |
| Q34520998 | A transmembrane glycoprotein, gp38, is a novel marker for immature hepatic progenitor cells in fetal mouse livers |
| Q42292310 | Antitumor activity of chLpMab-2, a human-mouse chimeric cancer-specific antihuman podoplanin antibody, via antibody-dependent cellular cytotoxicity |
| Q38764836 | Antitumor effect of novel anti-podoplanin antibody NZ-12 against malignant pleural mesothelioma in an orthotopic xenograft model. |
| Q64966742 | Blocking podoplanin suppresses growth and pulmonary metastasis of human malignant melanoma. |
| Q38905443 | Characterization of monoclonal antibody LpMab-3 recognizing sialylated glycopeptide of podoplanin |
| Q39311213 | Chimeric anti-podoplanin antibody suppresses tumor metastasis through neutralization and antibody-dependent cellular cytotoxicity. |
| Q37648097 | Development and characterization of anti-glycopeptide monoclonal antibodies against human podoplanin, using glycan-deficient cell lines generated by CRISPR/Cas9 and TALEN. |
| Q42290572 | Development of RAP Tag, a Novel Tagging System for Protein Detection and Purification. |
| Q80600955 | Development of murine hepatic sinusoidal endothelial cells characterized by the expression of hyaluronan receptors |
| Q58568945 | Establishment of P38Bf, a Core-Fucose-Deficient Mouse-Canine Chimeric Antibody Against Dog Podoplanin |
| Q64070235 | Establishment of a monoclonal antibody PMab-225 against alpaca podoplanin for immunohistochemical analyses |
| Q64088890 | Establishment of a monoclonal antibody PMab-233 for immunohistochemical analysis against Tasmanian devil podoplanin |
| Q34160649 | Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas |
| Q34522088 | Expression of Aggrus/podoplanin in bladder cancer and its role in pulmonary metastasis |
| Q84800178 | Expression of Podoplanin in Epithelial Ovarian Carcinomas and its Potential as a Marker for Clear Cell Adenocarcinoma |
| Q47161245 | Expression of podoplanin in stromal fibroblasts plays a pivotal role in the prognosis of patients with pancreatic cancer |
| Q83532352 | Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas |
| Q42099799 | Genome-wide gene expression profiling of testicular carcinoma in situ progression into overt tumours |
| Q60501370 | Identity of M2A (D2-40) antigen and gp36 (Aggrus, T1A-2, podoplanin) in human developing testis, testicular carcinoma in situ and germ-cell tumours |
| Q48455787 | Immunohistochemical analysis-based proteomic subclassification of newly diagnosed glioblastomas |
| Q54979905 | Interaction between oral squamous cell carcinoma cells and fibroblasts through TGF-β1 mediated by podoplanin. |
| Q35975006 | LpMab-12 Established by CasMab Technology Specifically Detects Sialylated O-Glycan on Thr52 of Platelet Aggregation-Stimulating Domain of Human Podoplanin |
| Q55100500 | LpMab-23-recognizing cancer-type podoplanin is a novel predictor for a poor prognosis of early stage tongue cancer. |
| Q38930784 | MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein |
| Q61801152 | PMab-219: A monoclonal antibody for the immunohistochemical analysis of horse podoplanin |
| Q92138458 | PMab-235: A monoclonal antibody for immunohistochemical analysis against goat podoplanin |
| Q48367537 | Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis. |
| Q63407986 | Platelet CLEC-2 and podoplanin in cancer metastasis |
| Q36880332 | Platelet aggregation in the formation of tumor metastasis |
| Q38663138 | Platelet-activating factor podoplanin: from discovery to drug development |
| Q61446725 | Podoplanin (PDPN) affects the invasiveness of thyroid carcinoma cells by inducing ezrin, radixin and moesin (E/R/M) phosphorylation in association with matrix metalloproteinases |
| Q26749146 | Podoplanin - a small glycoprotein with many faces |
| Q40546654 | Podoplanin Expression in Canine Melanoma. |
| Q33826371 | Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregation |
| Q42367646 | Podoplanin is a negative regulator of Th17 inflammation |
| Q55470653 | Podoplanin is expressed in subsets of tumors of the central nervous system. |
| Q33607564 | Podoplanin promotes progression of malignant pleural mesothelioma by regulating motility and focus formation |
| Q85047131 | Podoplanin, a novel marker for seminoma: A comparison study evaluating immunohistochemical expression of podoplanin and OCT3/4 |
| Q36891662 | Podoplanin-mediated TGF-β-induced epithelial-mesenchymal transition and its correlation with bHLH transcription factor DEC in TE-11 cells |
| Q38241783 | Podoplanin: a novel regulator of tumor invasion and metastasis |
| Q86853699 | Prognostic value of podoplanin expression in oral squamous cell carcinoma--a regression model auxiliary to UICC classification |
| Q33277291 | Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells |
| Q36546538 | The chimeric antibody chLpMab-7 targeting human podoplanin suppresses pulmonary metastasis via ADCC and CDC rather than via its neutralizing activity. |
| Q59811977 | The mouse-canine chimeric anti-dog podoplanin antibody P38B exerts antitumor activity in mouse xenograft models |
| Q41866316 | The multifaceted role of podoplanin expression in hepatocellular carcinoma |
| Q28221740 | The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis |
| Q64101494 | Therapeutic efficacy evaluation of radioimmunotherapy with Y-labeled anti-podoplanin antibody NZ-12 for mesothelioma |
| Q36808641 | Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions. |
Search more.